カテゴリ： GlobalData, ルクセンブルク, 企業調査

Eurofins Scientific SE (ERF)：製薬・医療：M&Aディール及び事業提携情報

◆英語タイトル：Eurofins Scientific SE (ERF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA904C9951
◆発行会社（調査会社）：GlobalData
◆発行日：2018年11月
◆ページ数：92
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ルクセンブルク
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Eurofins Scientific SE (Eurofins) is a life sciences company, which provides a range of analytical testing services to clients in various industries. The company offers food and feed testing, biopharma services, pharma discovery services, genomic pharma services, pharma early development, pharma central laboratory, biopharma product testing, genomic services, agro-science services, product testing, forensic services, environmental testing and Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) services. Its analytical methods help in evaluating the safety, identity, composition, origin, authenticity and purity of biological products and substances. It harnesses its expertise in logistics and information technology to deliver a range of services. The company operates across Europe, North and South America, and Asia-Pacific. Eurofins is headquartered in Luxembourg.

Eurofins Scientific SE (ERF) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Eurofins Scientific SE, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Eurofins Scientific SE, Medical Devices Deals, 2012 to YTD 2018 11
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Eurofins Scientific to Acquire Testing Business from Exova 14
Amatsigroup Acquires R&D Center from Pierre Fabre Labs 15
Eurofins Scientific Acquires Assets of Discovery and Development Solutions Business of Merck 16
Viracor-IBT Labs Completes Acquisition Of Lab Operations Of National Institute of Transplantation 17
Venture Financing 18
Diatherix Secures Additional US$0.53 Million In Venture Financing 18
Partnerships 19
GATC Biotech Enters into Agreement with University of Konstanz 19
Diatherix Labs Enters into Research Agreement with Vanderbilt University Medical Center 20
Qiagen Enters into Agreement with GATC Biotech 21
Merger 22
Bactimm Farma And Proxy Labs Merge To Form Sinensis Life Sciences 22
Equity Offering 23
Eurofins Scientific Raises USD347.1 Million in Private Placement of Shares 23
Eurofins Scientific Raises USD333 Million in Private Placement of Shares 24
Debt Offering 25
Eurofins Scientific Raises USD464.7 Million in Public Offering of 3.25% Bonds 25
Eurofins Scientific Raises USD745.3 Million in Public Offering of 2.125% Bonds Due 2024 26
Eurofins Scientific Raises USD554 Million in Public Offering of 3.375% Bonds Due 2023 27
Eurofins Scientific Prices USD322 Million in Public Offering of 4.87% Bond Due 2023 28
Eurofins Scientific Raises USD579 Million in Public Offering of 2.25% Bond Due 2022 29
Eurofins Prices Public Offering Of Bonds Due 2018 For US$405.1 Million 30
Acquisition 31
Eurofins Acquires Covance from LabCorp 31
Eurofins Scientific to Acquire PHAST 33
Eurofins Scientific Acquires Selcia 34
Eurofins Pharma Services Acquires Majority Stake in Advinus Therapeutics 35
Eurofins Scientific to Acquire DiscoverX 37
Eurofins Scientific Acquires Amatsigroup from Ekkio Capital 38
Eurofins GSC Lux Acquires ANA Laboratories 39
Eurofins Scientific Acquires Alphora Research 40
Eurofins Scientific to Acquire GATC Biotech 41
Amatsigroup Acquires Disposable-Lab 42
Eurofins Scientific to Acquire Villapharma Research 43
Amatsigroup Acquires Q-Biologicals 44
Eurofins Scientific Acquires Sinensis Life Sciences 45
Eurofins Scientific Acquires 75% Stake in Emory Genetics Lab for USD40 Million 46
Eurofins Scientific Acquires QC Laboratories (QCL) 47
Amatsi Acquires Seps Pharma 48
Eurofins Scientific to Acquire SF Analytical Labs 49
Eurofins Genomics Acquires VBC-Biotech 50
Eurofins Scientific Completes Acquisition of Viracor-IBT Labs For USD255 Million 51
Eurofins Scientific Acquires IDmyk 52
Eurofins Scientific Acquires 81% Stake In Agrisearch Services 53
Eurofins Discovery Services Acquires Majority Stake In Cerep 54
Eurofins Scientific Acquires Aros Applied Biotech, Genomic Solutions Provider 55
Proxy Labs Acquires MicroSafe Laboratories From Millipore 56
Eurofins Scientific SE – Key Competitors 57
Eurofins Scientific SE – Key Employees 58
Eurofins Scientific SE – Locations And Subsidiaries 59
Head Office 59
Other Locations & Subsidiaries 59
Recent Developments 63
Financial Announcements 63
Oct 23, 2018: Eurofins posts strong revenue growth in Q3 2018 (EUR 955m, +30.6% yoy including over 5% organic growth) and raises its objectives for 2019-2020 – Revenues objective for 2020 now set at EUR 5bn 63
Jul 31, 2018: Eurofins delivers strong revenue, profitability and cash flow growth in H1 2018 65
Jun 26, 2018: Eurofins raises its revenues objectives for 2018 to EUR 3.8bn (4bn pro-forma), to 4.3bn for 2019 and to 4.7bn for 2020 71
Apr 24, 2018: Eurofins revenues grow +23% in Q1 2018 to EUR 839m 72
Mar 06, 2018: Eurofins exceeds its recently-upgraded 2017 objectives on a strong growth momentum and raises its objectives for 2018 73
Oct 24, 2017: After Strong NM 2017 Performance Eurofins Brings Forward by 1 Year, to 2019, Its EUR 4bn Annual Revenues Objective 80
Aug 30, 2017: Eurofins Reports Solid H1 2017 Results 81
Feb 28, 2017: Eurofins: Full Year 2016 Results 86
Product News 91
Oct 02, 2018: Eurofins BioPharma Product Testing Ireland opened the new extension in Dungarvan 91
Appendix 92
Methodology 92
About GlobalData 92
Contact Us 92
Disclaimer 92

List of Tables
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Eurofins Scientific SE, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Eurofins Scientific SE, Deals By Therapy Area, 2012 to YTD 2018 10
Eurofins Scientific SE, Medical Devices Deals, 2012 to YTD 2018 11
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Eurofins Scientific to Acquire Testing Business from Exova 14
Amatsigroup Acquires R&D Center from Pierre Fabre Labs 15
Eurofins Scientific Acquires Assets of Discovery and Development Solutions Business of Merck 16
Viracor-IBT Labs Completes Acquisition Of Lab Operations Of National Institute of Transplantation 17
Diatherix Secures Additional US$0.53 Million In Venture Financing 18
GATC Biotech Enters into Agreement with University of Konstanz 19
Diatherix Labs Enters into Research Agreement with Vanderbilt University Medical Center 20
Qiagen Enters into Agreement with GATC Biotech 21
Bactimm Farma And Proxy Labs Merge To Form Sinensis Life Sciences 22
Eurofins Scientific Raises USD347.1 Million in Private Placement of Shares 23
Eurofins Scientific Raises USD333 Million in Private Placement of Shares 24
Eurofins Scientific Raises USD464.7 Million in Public Offering of 3.25% Bonds 25
Eurofins Scientific Raises USD745.3 Million in Public Offering of 2.125% Bonds Due 2024 26
Eurofins Scientific Raises USD554 Million in Public Offering of 3.375% Bonds Due 2023 27
Eurofins Scientific Prices USD322 Million in Public Offering of 4.87% Bond Due 2023 28
Eurofins Scientific Raises USD579 Million in Public Offering of 2.25% Bond Due 2022 29
Eurofins Prices Public Offering Of Bonds Due 2018 For US$405.1 Million 30
Eurofins Acquires Covance from LabCorp 31
Eurofins Scientific to Acquire PHAST 33
Eurofins Scientific Acquires Selcia 34
Eurofins Pharma Services Acquires Majority Stake in Advinus Therapeutics 35
Eurofins Scientific to Acquire DiscoverX 37
Eurofins Scientific Acquires Amatsigroup from Ekkio Capital 38
Eurofins GSC Lux Acquires ANA Laboratories 39
Eurofins Scientific Acquires Alphora Research 40
Eurofins Scientific to Acquire GATC Biotech 41
Amatsigroup Acquires Disposable-Lab 42
Eurofins Scientific to Acquire Villapharma Research 43
Amatsigroup Acquires Q-Biologicals 44
Eurofins Scientific Acquires Sinensis Life Sciences 45
Eurofins Scientific Acquires 75% Stake in Emory Genetics Lab for USD40 Million 46
Eurofins Scientific Acquires QC Laboratories (QCL) 47
Amatsi Acquires Seps Pharma 48
Eurofins Scientific to Acquire SF Analytical Labs 49
Eurofins Genomics Acquires VBC-Biotech 50
Eurofins Scientific Completes Acquisition of Viracor-IBT Labs For USD255 Million 51
Eurofins Scientific Acquires IDmyk 52
Eurofins Scientific Acquires 81% Stake In Agrisearch Services 53
Eurofins Discovery Services Acquires Majority Stake In Cerep 54
Eurofins Scientific Acquires Aros Applied Biotech, Genomic Solutions Provider 55
Proxy Labs Acquires MicroSafe Laboratories From Millipore 56
Eurofins Scientific SE, Key Competitors 57
Eurofins Scientific SE, Key Employees 58
Eurofins Scientific SE, Subsidiaries 59

List of Figures
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Eurofins Scientific SE, Medical Devices Deals, 2012 to YTD 2018 11

★海外企業調査レポート[Eurofins Scientific SE (ERF)：製薬・医療：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Michael J Fox Foundation for Parkinson’s Research-製薬・医療分野：企業M&A・提携分析
    Summary Michael J Fox Foundation for Parkinson's Research (Michael J. Fox) is a research foundation that conducts research on Parkinson's disease. The foundation offers research and development of therapies. It provides drug development and other research activities in the area of Parkinson's diseas …
  • Caja Laboral Popular Coop. de Credito：企業の戦略・SWOT・財務情報
    Caja Laboral Popular Coop. de Credito - Strategy, SWOT and Corporate Finance Report Summary Caja Laboral Popular Coop. de Credito - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Dairygold Co-operative Society Ltd：企業の戦略的SWOT分析
    Dairygold Co-operative Society Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Hot Topic, Inc.：企業の戦略・SWOT・財務情報
    Hot Topic, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hot Topic, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Kedrion SpA-製薬・医療分野：企業M&A・提携分析
    Summary Kedrion SpA (Kedrion) collects and fractionates blood plasma to develop, produce and distribute plasma-derived therapies. The company’s products are used for the treatment of rare and serious disorders such as hemophilia, immune deficiency and neurological disorders. It also offers products …
  • NTPC Ltd (NTPC)：電力：M&Aディール及び事業提携情報
    Summary NTPC Ltd (NTPC) is a Public sector undertaking energy conglomerate. It has presence in the entire value chain of the power generation business. The company produces electricity and sells that to state power utilities on wholesale basis. NTPC generates power using coal, gas, liquid fuel and h …
  • Shire Plc (SHP)-製薬・医療分野：企業M&A・提携分析
    Summary Shire Plc (Shire) is a biotechnology company that focuses on the research, development, manufacturing, marketing, distribution and sale of novel pharmaceuticals to serve patients with rare diseases and other highly specialized conditions. It provides products across various therapeutic areas …
  • Caspian Energy Inc (CKZ.H)：石油・ガス：M&Aディール及び事業提携情報
    Summary Caspian Energy Inc (CEI) is an independent upstream oil and gas company. It carries out the exploration, development, and production of oil and gas. and the company, along with its subsidiaries hold interests in Aral Petroleum Capital LLP, which holds an exclusive license to explore and deve …
  • Astron Corp Ltd (ATR)：企業の財務・戦略的SWOT分析
    Astron Corp Ltd (ATR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bank Of The Philippine Islands
    Bank Of The Philippine Islands - Strategy, SWOT and Corporate Finance Report Summary Bank Of The Philippine Islands - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Euronet Worldwide Inc (EEFT)：企業の財務・戦略的SWOT分析
    Euronet Worldwide Inc (EEFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Cogent Communications Holdings inc (CCOI)：企業の財務・戦略的SWOT分析
    Cogent Communications Holdings inc (CCOI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Golar LNG Ltd (GOL)：石油・ガス：M&Aディール及び事業提携情報
    Summary Golar LNG Limited (Golar LNG) is a midstream liquefied natural gas (LNG) company. It provides liquefaction, transport, storage, and re-gasification services to customers in the LNG industry. The company owns and operates LNG carriers and FSRUs; and develops FLNGVs. Through a joint venture wi …
  • Vectura Group Plc (VEC)：製薬・医療：M&Aディール及び事業提携情報
    Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) …
  • Spineology Inc：医療機器：M&Aディール及び事業提携情報
    Summary Spineology Inc (Spineology) is a medical device company that develops and designs spinal implants. The company offers products such as pedicular fixation system, interbody fusion system, deployable grafting system, amniotic fixation system, allografts, retractor system, liquid tissue matrix, …
  • Terme Dobrna D.D.
    Terme Dobrna D.D. - Strategy, SWOT and Corporate Finance Report Summary Terme Dobrna D.D. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • TBC Corp：企業の戦略・SWOT・財務分析
    TBC Corp - Strategy, SWOT and Corporate Finance Report Summary TBC Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Immune Design Corp (IMDZ)：企業の財務・戦略的SWOT分析
    Summary Immune Design Corp (Immune Design) is a clinical-stage immunotherapy company that discovers and develops in vivo immunotherapy treatments to target cancer and other chronic diseases. The company harnesses ZVex and GLAAS discovery platforms, to develop its product portfolio. Immune Design’s p …
  • MAXrad SOFTware (India) Pvt Ltd：企業の戦略・SWOT・財務分析
    MAXrad SOFTware (India) Pvt Ltd - Strategy, SWOT and Corporate Finance Report Summary MAXrad SOFTware (India) Pvt Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Warner Media LLC：企業の戦略的SWOT分析
    Warner Media LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆